Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA Maintaining Approval Output Despite Losing Staff
Aug 21 2025
•
By
Derrick Gingery
NDA and ANDA approvals were ahead or in line with the pace of prior years from January through June.
(Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Regulation
More from Policy & Regulation